Cutaneous manifestations of hospitalized coronavirus disease 2019 patients: a report of six cases with clinicopathologic features and viral RNA in situ hybridization
dc.contributor.author | Bitar, C. | |
dc.contributor.author | Chan, M.P. | |
dc.contributor.author | Harms, P.W. | |
dc.contributor.author | Fullen, D.R. | |
dc.contributor.author | Gudjonsson, J.E. | |
dc.contributor.author | Eshaq, M. | |
dc.contributor.author | Renati, S. | |
dc.contributor.author | Nikle, A.B. | |
dc.contributor.author | Allen, A. | |
dc.contributor.author | Hawkins, S.D. | |
dc.contributor.author | Huerta, T. | |
dc.contributor.author | Lowe, L. | |
dc.contributor.author | Andea, A.A. | |
dc.date.accessioned | 2021-01-05T18:46:19Z | |
dc.date.available | WITHHELD_11_MONTHS | |
dc.date.available | 2021-01-05T18:46:19Z | |
dc.date.issued | 2020-11 | |
dc.identifier.citation | Bitar, C.; Chan, M.P.; Harms, P.W.; Fullen, D.R.; Gudjonsson, J.E.; Eshaq, M.; Renati, S.; Nikle, A.B.; Allen, A.; Hawkins, S.D.; Huerta, T.; Lowe, L.; Andea, A.A. (2020). "Cutaneous manifestations of hospitalized coronavirus disease 2019 patients: a report of six cases with clinicopathologic features and viral RNA in situ hybridization." Journal of the European Academy of Dermatology and Venereology (11): e656-e659. | |
dc.identifier.issn | 0926-9959 | |
dc.identifier.issn | 1468-3083 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/163863 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.title | Cutaneous manifestations of hospitalized coronavirus disease 2019 patients: a report of six cases with clinicopathologic features and viral RNA in situ hybridization | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Dermatology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/163863/1/jdv16741.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/163863/2/jdv16741_am.pdf | |
dc.identifier.doi | 10.1111/jdv.16741 | |
dc.identifier.source | Journal of the European Academy of Dermatology and Venereology | |
dc.identifier.citedreference | Astuti I, Ysrafil X. Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐ 2): an overview of viral structure and host response. Diabetes Metab Syndr 2020; 14: 407 – 412. | |
dc.identifier.citedreference | Connors JM, Levy JH. COVID‐19 and its implications for thrombosis and anticoagulation. Blood 2020; 135: 2033 – 2040. | |
dc.identifier.citedreference | Jeong HS, Dominguez AR. Calciphylaxis: controversies in pathogenesis, diagnosis and treatment. Am J Med Sci 2016; 351: 217 – 227. | |
dc.identifier.citedreference | Mazori DR, Nagarajan S, Glick SA. Recurrent reactive infectious mucocutaneous eruption (RIME): insights from a child with three episodes. Pediatr Dermatol 2020. [Epub ahead of print] https://doi.org/10.1111/pde.14142 | |
dc.identifier.citedreference | Cucinotta D, Vanelli M. WHO declares COVID‐19 a pandemic. Acta Biomed 2020; 91: 157 – 160. | |
dc.identifier.citedreference | Recalcati S. Cutaneous manifestations in COVID‐ 19: a first perspective. J Eur Acad Dermatol Venereol 2020; 34: e212 – e213. | |
dc.identifier.citedreference | Riphagen S, Gomez X, Gonzalez‐Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID‐19 pandemic. Lancet (London, England) 2020; 395: 1607 – 1608. | |
dc.identifier.citedreference | Shepardson KM, Larson K, Johns LL et al. IFNAR2 is required for anti‐influenza immunity and alters susceptibility to post‐influenza bacterial superinfections. Front Immunol 2018; 9: 2589. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.